What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Stroke
- Surgery
Michael D. Hill spends much of his time researching Stroke, Surgery, Internal medicine, Thrombolysis and Cardiology.
His Stroke research incorporates elements of Prospective cohort study, Randomized controlled trial and Physical therapy.
His biological study spans a wide range of topics, including Odds ratio and Cerebral infarction.
His study in Thrombolysis is interdisciplinary in nature, drawing from both Clinical trial, Central nervous system disease, Ischaemic stroke, Brain ischemia and T-plasminogen activator.
The various areas that Michael D. Hill examines in his Cardiology study include Triage and Hazard ratio.
In his research, Occlusion and Middle cerebral artery is intimately related to Radiology, which falls under the overarching field of Vascular disease.
His most cited work include:
- Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials (2631 citations)
- Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis (2081 citations)
- Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke (1385 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Stroke, Internal medicine, Cardiology, Surgery and Thrombolysis.
His work in Stroke addresses subjects such as Radiology, which are connected to disciplines such as Occlusion.
Cardiology is often connected to Magnetic resonance imaging in his work.
His Revascularization research extends to Surgery, which is thematically connected.
His research in Thrombolysis tackles topics such as Tissue plasminogen activator which are related to areas like Fibrinolytic agent.
His work in Modified Rankin Scale addresses issues such as Odds ratio, which are connected to fields such as Confidence interval.
He most often published in these fields:
- Stroke (62.63%)
- Internal medicine (32.78%)
- Cardiology (24.44%)
What were the highlights of his more recent work (between 2019-2021)?
- Stroke (62.63%)
- Internal medicine (32.78%)
- Cardiology (24.44%)
In recent papers he was focusing on the following fields of study:
Michael D. Hill mainly focuses on Stroke, Internal medicine, Cardiology, Acute ischemic stroke and Emergency medicine.
His research integrates issues of Endovascular treatment and Randomized controlled trial in his study of Stroke.
His study in the fields of Large vessel occlusion, Atrial fibrillation, Clinical trial and Infarction under the domain of Internal medicine overlaps with other disciplines such as In patient.
He has included themes like Cross-sectional study, Thrombolysis and Emergency department in his Emergency medicine study.
His Modified Rankin Scale research includes themes of Meta-analysis and Odds ratio.
His work on Endovascular therapy is being expanded to include thematically relevant topics such as Surgery.
Between 2019 and 2021, his most popular works were:
- Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial. (102 citations)
- Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children. (47 citations)
- MeVO: the next frontier? (21 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Stroke
- Surgery
His primary areas of study are Stroke, Internal medicine, Cardiology, Emergency medicine and Acute ischemic stroke.
A large part of his Stroke studies is devoted to Thrombolysis.
The Middle cerebral artery research Michael D. Hill does as part of his general Cardiology study is frequently linked to other disciplines of science, such as Medium vessel, therefore creating a link between diverse domains of science.
His work on Triage as part of general Emergency medicine study is frequently linked to Quality-adjusted life year, therefore connecting diverse disciplines of science.
His Acute ischemic stroke study combines topics from a wide range of disciplines, such as Endovascular treatment, White matter, Acute stroke and Computed tomography.
His Randomized controlled trial research incorporates themes from Infarct volume, Placebo and Clinical trial.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
